Синдром диссеминированного внутрисосудистого свертывания крови - Макацария А.Д.
ISBN 5-8249-0078-7
Скачать (прямая ссылка):
295. Rodnguez-Erdmann F. Bleeding due to increased intravascular blood coagulation: hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies) N. Engl JMed 1965; 273:1370.
296. Rylatt DB, Blake AS, Cottis LE, et al: An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 31:767, 1983
297. Schjetlein R. Haugen G, Wisloff F: Markers of intravascular coagulation and fibrinolysis in preeclampsia: Association with intrauterine growth retardation. Acta Obstet Gynecol Scand 76:541,1997
298. Sheikh RA, Yasmeen S, Pauly MP, et al: Spontaneous intrahepatic hemorrhage and hepatic rupture in the HELLP syndrome: Four cases and a review. J Clin Gastroenterol 28:823,1999
299. Sorensen JV, Jensen HP, Rahr HR, et al: F 11- 2 and FPA in urine from patients with multiple trauma and healthy individuals: A pilot study. Thromb Res 67:429,1992
300. Sperry K: Amniotic fluid embolism: To understand an enigma.
IAMA 255:2183, 1986
301. Stancheva A., Danchev D. Deffect of s.c. therapeutical doses of low mole molecular weight heparin on thrombophilia marcers.// Thromb.Haemost.,-1999.-9.-p.682-68:
493
302. Stein SF, Fulenwider JT, Ansley JD: Accelerated fibrinogen and platelet destruction after peritoneovenous shunting. Arch Intern Med 141:1149,1981
303. Steiner PE, Lushbaugh CC Maternal pulmonary embolism by amniotic fluidJAMA 1941; 117:1245
304. StibbeJ, Gomes M, de Ouda A: The value of the FM-test (KABl) and thrombin-antithrombin-III complexes (TAT) in the management of DIC in cancer. Thromb Haemost 65:1238, 1989
305. Stone JH: HELLP syndrome: Hemolysis, elevated liver enzymes, and low platelets. JAMA 280:559,1998
306. Strickland MA, Bates AW, Whitworth HS, et al: Amniotic fluid embolism: Prophylaxis with heparin and aspirin. South Med J 78:377,1985
307. Sutton DM. Intravascular coagulation in abruptio placenta. AmJ Obstet Gynecol 1971; 109:604
308. Suzuki S, Morishita S: Hypercoagulability and DIC in high-risk infants. Semin Thromb Hemost 24:463, 1998
309. Takahashi H, T Koike, N Yoshida, O Kitahara, et al: Excessive fibrinolysis in suspected amyloidosis: Demonstration of plasmin-al-pha-2 plasmin inhibitor complex and von Willebrand factor fragment in plasma. AmJ Hematol 23:133, 1986
310. Takahashi H, Hanano M, Takizawa S, et al: Plasmin-alpha-2-plas-min inhibitor complex in plasma of patients with disseminated intravascular coagulation. AmJ Hematol 28:162,1988
311. Talbot M: Biology of recombinant hirudin (CGP 39393): A new prospect in the treatment of thrombosis. Semin Thromb Hemost 15:293,1989
312. Verduzco RL, Gonzalez PE, Manffrini MF, et al: D-dimer in different stages of pregnancy toxemia. A pilot study. Ginecol Obstet Me\ 66:77,1998
313. Yao T, Yao H, Wang H: Diagnosis and treatment of nephrotic syndrome during pregnancy. Chin Med J (Engl) 109:471,1996
314. Van Heerden PV, Webb SA, Нее G, et al: Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxaemia. Anaesth Intensive Care. 24:87,1996
315. Vedernikov YP, Saade GR, Zlatnik M, et al: The effect of amniotic fluid on the human omental artery in vitro. Am J Obstet Gynecol 180:454,1999
316. Vigi!-De Gracia P, Garcia-Caceres E: Dexamethasone in the postpartum treatment of HELLP syndrome. Int J Gynaecol Obstet 59:217, 1997
317. Vinazzer II: Antithrombin III in shock and disseminated intravascular coagulation. * Clinical Applied Thrombosis Hemostasis 1:62, 1995
494
318. Vinazzer H: Hereditary and acquired antithrombin deficiency. Semin Thromb Homost 25:257,1999
319. WarrTA,RaoLHV,RapaportSI.DIC,Blood 1990; 75:1841.
320. Weemhoff RA, van Loon AJ, Aarnoudse JG: Liver rupture in pregnancy: A life-threatening complication of the HELLP syndrome. NedTijdschr Geneeskd 140:2140, 1996
321. Weltermann A, Mitterbauer GJ, Mittebauer M, et al: Disseminated intravascular coagulation (DIG) with massive hyperfibrinolysis in metastatic uterine cancer: Observations on the effects on the coagulopathy of various treatments. Weincr Klin Wo-chenschr 110:53, 1998
322. Wiman B, Jacobsson L, Andersson M, et al: Determination of plas-min-alpha-2-plasmin inhibitor complex in plasma samples by means of a radioimmunoassay. Scand J Clin Lab Invest 43:27, 1983
323. Yalcin ОТ, Sener T, Hassa H, et al: Effects of postpartum corticosteroids in patients with HELLP syndrome. Int J Gynaecol Obstet 61:141, 1998
324. Yoshikawa T, Tanaka KR, Guze LB. Infection and DIC Medicine (Baltimore) 1971; 50:237
325. Zahavi J, Kakkar W: ?-thromboglobulin A specific marker of in vivo platelet release reaction. Thromb Haemost 44:23,1980
Лицензия ЛР № 066029 от 28.07.98 г. Подписано в печать 12.08.2002.
Формат 60x90 1/16. Печать офсетная. Усл. п.л. 31
Тираж 2 500 экз. Заказ 6578
Отпечатано в полном соответствии с качеством предоставленных диапозитивов
в ППП «Типография «Наука» 121099, Москва, Шубинский пер., 6